Founded in 1999, RK Ventures Group is a well-known venture capital firm based in New York. The firm primarily focuses on investing in seed and early-stage companies in the financial services, software, and biotech sectors. With a typical investment range of $10-50 million, RK Ventures Group has a track record of successful exits, particularly in 2010. The firm has a preference for startups with fewer founders and those that have been in operation for 2-3 years. Some notable portfolio companies include Xenex, Respicardia, and Redpoint Bio. RK Ventures Group stands out for its active involvement in supporting entrepreneurs who are passionate about their vision and possess the necessary skills and experience to bring their ideas to life.